BDRX logo

Biodexa Pharmaceuticals Plc (BDRX)

Profile

Full Name

Biodexa Pharmaceuticals Plc

Ticker

NASDAQ: BDRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

December 7, 2015

Indexes

Not included

Website

https://www.biodexapharma.com

Employees

13

Key Details

Price

$5.54(+1.28%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(-100.00% YoY)

Annual EPS

$0.00(+100.00% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.54
    BDRX price is $5.54

    30-Day Relative Volume

    0.54
    BDRX 30-day relative volume is 0.54

    Price Performance

    Price Most recent change

    +1.28%
    BDRX price was up +1.28% on Aug 29, 2025

    Price YTD change

    -86.32%
    BDRX price is down -86.32% since January 1st

    Price 1-year change

    -95.99%
    BDRX price is down -95.99% year-on-year

    Price 3-year change

    -100%
    BDRX price is down -100% over the past 3 years

    Price Range

    Price All-time high

    $161.80M
    BDRX price is currently -100.00% below its historical high of $161.80 million

    Price 3-year low

    $5.33
    BDRX price is currently +3.86% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $3.43M
    BDRX market capitalization is $3.43 million

    Market cap 3-year change

    +100%
    BDRX market capitalization is up +100% over the past 3 years

    Market cap All-time high

    $13.05M
    BDRX market capitalization is currently -73.70% below its historical high of $13.05 million

    Market cap sector rank

    7.63%
    BDRX market capitalization is higher than 7.63% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +966.27%
    BDRX shares outstanding is up +966.27% year-on-year

    Shares Outstanding 3-Year Change

    +100%
    BDRX shares outstanding is up +100% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.16
    BDRX beta is 1.16

    200-day SMA

    $24.08
    BDRX price is currently -77.00% below its 200-day simple moving average

    50-day SMA

    $7.86
    BDRX price is currently -29.54% below its 50-day simple moving average

    RSI

    29.25
    BDRX 14-day relative strength index is 29.25

    Volume

    0.54
    BDRX 30-day relative volume is 0.54

    ATR

    $0.58
    BDRX average true range is $0.58

    10-day Historical Volatility

    75.81%
    BDRX 10-day historical volatility is 75.81%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    BDRX annual revenue is $0.00

    Revenue Analysts estimate

    -
    BDRX annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    -100%
    BDRX annual revenue is down -100% year-on-year

    Revenue Sector rank

    28.72%
    BDRX annual revenue is higher than 28.72% of companies in Healthcare sector

    EPS

    EPS

    $0.00
    BDRX annual earnings per share is $0.00

    EPS Analysts estimate

    -$0.40
    BDRX annual earnings per share is currently -100.00% lower than the consensus analysts' forecast

    EPS 1-year change

    +100%
    BDRX annual earnings per share is up +100% year-on-year

    EPS Sector rank

    82.48%
    BDRX annual earnings per share is higher than 82.48% of companies in Healthcare sector

    Profit

    Gross profit

    -$324.60K
    BDRX annual gross profit is -$324.60 thousand

    Gross margin

    -
    BDRX annual gross profit margin value is unknown

    Operating profit

    -$11.91M
    BDRX annual operating income is -$11.91 million

    Operating margin

    -
    BDRX annual operating profit margin value is unknown

    Net income

    -$7.32M
    BDRX annual net profit is -$7.32 million

    Net margin

    -
    BDRX annual net profit margin value is unknown

    Expenses

    Total expenses

    $7.32M
    BDRX annual total expenses is $7.32 million

    Operating expenses

    $11.59M
    BDRX annual total operating expenses is $11.59 million

    Cost of goods sold

    $324.60K
    BDRX annual cost of goods sold is $324.60 thousand

    Selling, general & administrative expenses

    $0.00
    BDRX annual SGA is $0.00

    Depreciation and amortization

    $324.60K
    BDRX annual depreciation & amortization is $324.60 thousand

    Interest expense

    $0.00
    BDRX annual interest expense is $0.00

    Income tax

    -$319.50K
    BDRX annual income tax is -$319.50 thousand

    EBIT & EBITDA

    EBIT

    -$11.91M
    BDRX annual earnings before interest & taxes is -$11.91 million

    EBITDA

    -$11.59M
    BDRX annual EBITDA is -$11.59 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $18.51M
    BDRX annual total assets is $18.51 million

    Non current assets

    $7.49M
    BDRX annual long term assets is $7.49 million

    Current assets

    $11.03M
    BDRX annual total current assets is $11.03 million

    Cash and cash equivalents

    $2.09M
    BDRX annual cash & cash equivalents is $2.09 million

    Accounts receivable

    $13.80K
    BDRX annual accounts receivable is $13.80 thousand

    Inventory

    $0.00
    BDRX annual inventory is $0.00

    Liabilities

    Total liabilities

    $8.09M
    BDRX annual total liabilities is $8.09 million

    Long term liabilities

    $1.78M
    BDRX annual total long term liabilities is $1.78 million

    Current liabilities

    $6.30M
    BDRX annual total current liabilities is $6.30 million

    Accounts payable

    $885.40K
    BDRX annual accounts payable is $885.40 thousand

    Debt

    Total debt

    $910.50K
    BDRX annual total debt is $910.50 thousand

    Total debt 1-year change

    +53.93%
    BDRX annual total debt is up +53.93% year-on-year

    Long term debt

    $147.80K
    BDRX annual long term debt is $147.80 thousand

    Short term debt

    $762.70K
    BDRX annual short term debt is $762.70 thousand

    Equity & Capital

    Shareholders equity

    $10.42M
    BDRX annual stockholders equity is $10.42 million

    Book value

    $297.20K
    BDRX annual book value is $297.20 thousand

    Retained earnings

    -$122.01M
    BDRX annual retained earnings is -$122.01 million

    Working capital

    $4.73M
    BDRX annual working capital is $4.73 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$15.44M
    BDRX annual cash flow from operations is -$15.44 million

    Cash from operations 1-year change

    -83.61%
    BDRX annual cash flow from operations is down -83.61% year-on-year

    Cash from investing

    -$989.00K
    BDRX annual cash flow from investing activities is -$989.00 thousand

    Cash from investing 1-year change

    -135.36%
    BDRX annual cash flow from investing activities is down -135.36% year-on-year

    Cash from financing

    $10.93M
    BDRX annual cash flow from financing activities is $10.93 million

    Cash from financing 1-year change

    -14.09%
    BDRX annual cash flow from financing activities is down -14.09% year-on-year

    CAPEX

    CAPEX

    $989.00K
    BDRX annual capital expenditures is $989.00 thousand

    CAPEX 1-year change

    +202.54%
    BDRX annual capital expenditures is up +202.54% year-on-year

    Free Cash Flow

    Free cash flow

    -$16.43M
    BDRX annual free cash flow is -$16.43 million

    Free cash flow 1-year change

    -88.06%
    BDRX annual free cash flow is down -88.06% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    BDRX annual gross profit margin value is unknown

    Operating margin

    -
    BDRX annual operating profit margin value is unknown

    Net margin

    -
    BDRX annual net profit margin value is unknown

    ROA & ROE

    ROA

    -45.83%
    BDRX annual return on assets is -45.83%

    ROE

    -89.35%
    BDRX annual return on equity is -89.35%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    BDRX price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    BDRX price to earnings ratio is unknown

    PB Ratio

    PB ratio

    0.33
    BDRX price to book ratio is 0.33

    PB ratio Sector rank

    21.7%
    BDRX price to book ratio is higher than 21.7% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    BDRX price to sales ratio value is unknown

    PS ratio Sector rank

    -
    BDRX price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $2.25M
    BDRX enterprise value is $2.25 million

    Enterprise value Sector rank

    15.43%
    BDRX enterprise value is higher than 15.43% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -
    BDRX EV/EBITDA value is unknown

    EV/EBITDA Sector rank

    -
    BDRX EV/EBITDA is unknown

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    1.75
    BDRX annual current ratio is 1.75

    Quick ratio

    1.75
    BDRX annual quick ratio is 1.75

    Leverage

    Debt to equity

    0.09
    BDRX annual debt to equity ratio is 0.09

    Interest coverage ratio

    -
    BDRX annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    BDRX piotroski f-score value is unknown

    Altman Z-Score

    -10.79
    BDRX altman z-score is -10.79

    Analyst ratings

    Recent major analysts updates

    Feb 8, 24 Ladenburg Thalmann
    Buy

    Institutional Ownership

    Screeners with BDRX included

    Growing Shares Outstanding
    Stocks with high beta
    UK stocks
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Biodexa Pharmaceuticals Plc?
    • Does Biodexa Pharmaceuticals Plc pay dividends?
    • What sector is Biodexa Pharmaceuticals Plc in?
    • What industry is Biodexa Pharmaceuticals Plc in?
    • What country is Biodexa Pharmaceuticals Plc based in?
    • When did Biodexa Pharmaceuticals Plc go public?
    • Is Biodexa Pharmaceuticals Plc in the S&P 500?
    • Is Biodexa Pharmaceuticals Plc in the NASDAQ 100?
    • Is Biodexa Pharmaceuticals Plc in the Dow Jones?
    • When was Biodexa Pharmaceuticals Plc's last earnings report?
    • When does Biodexa Pharmaceuticals Plc report earnings?

    What is the ticker symbol for Biodexa Pharmaceuticals Plc?

    The ticker symbol for Biodexa Pharmaceuticals Plc is NASDAQ:BDRX

    Does Biodexa Pharmaceuticals Plc pay dividends?

    No, Biodexa Pharmaceuticals Plc does not pay dividends

    What sector is Biodexa Pharmaceuticals Plc in?

    Biodexa Pharmaceuticals Plc is in the Healthcare sector

    What industry is Biodexa Pharmaceuticals Plc in?

    Biodexa Pharmaceuticals Plc is in the Biotechnology industry

    What country is Biodexa Pharmaceuticals Plc based in?

    Biodexa Pharmaceuticals Plc is headquartered in United Kingdom

    When did Biodexa Pharmaceuticals Plc go public?

    Biodexa Pharmaceuticals Plc's initial public offering (IPO) was on December 7, 2015

    Is Biodexa Pharmaceuticals Plc in the S&P 500?

    No, Biodexa Pharmaceuticals Plc is not included in the S&P 500 index

    Is Biodexa Pharmaceuticals Plc in the NASDAQ 100?

    No, Biodexa Pharmaceuticals Plc is not included in the NASDAQ 100 index

    Is Biodexa Pharmaceuticals Plc in the Dow Jones?

    No, Biodexa Pharmaceuticals Plc is not included in the Dow Jones index

    When was Biodexa Pharmaceuticals Plc's last earnings report?

    Biodexa Pharmaceuticals Plc's most recent earnings report was on April 19, 2024

    When does Biodexa Pharmaceuticals Plc report earnings?

    The date for Biodexa Pharmaceuticals Plc's next earnings report has not been announced yet
    On this page